276 related articles for article (PubMed ID: 31742741)
1. Altered Pharmacokinetics and Dosing of Liposomal Amphotericin B and Isavuconazole during Extracorporeal Membrane Oxygenation.
Zhao Y; Seelhammer TG; Barreto EF; Wilson JW
Pharmacotherapy; 2020 Jan; 40(1):89-95. PubMed ID: 31742741
[TBL] [Abstract][Full Text] [Related]
2. Apparent interference with extracorporeal membrane oxygenation by liposomal amphotericin B in a patient with disseminated blastomycosis receiving continuous renal replacement therapy.
Branick K; Taylor MJ; Trump MW; Wall GC
Am J Health Syst Pharm; 2019 May; 76(11):810-813. PubMed ID: 30994894
[TBL] [Abstract][Full Text] [Related]
3. Treatment of pulmonary blastomycosis with high-dose liposomal amphotericin B in a patient receiving extracorporeal membrane oxygenation.
Servais R; Ammar MA; Gurnani PK
BMJ Case Rep; 2019 Jun; 12(6):. PubMed ID: 31253662
[TBL] [Abstract][Full Text] [Related]
4. Liposomal amphotericin B pharmacokinetics in a patient treated with extracorporeal membrane oxygenation.
Foulquier JB; Berneau P; Frérou A; Verdier MC; Saint-Marcoux F; Petitcollin A; Tron C; Bellissant E; Lemaitre F
Med Mal Infect; 2019 Feb; 49(1):69-71. PubMed ID: 30466763
[No Abstract] [Full Text] [Related]
5. Decreased isavuconazole trough concentrations in the treatment of invasive aspergillosis in an adult patient receiving extracorporeal membrane oxygenation support.
Miller M; Kludjian G; Mohrien K; Morita K
Am J Health Syst Pharm; 2022 Jul; 79(15):1245-1249. PubMed ID: 35377411
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and Dosing of Anti-infective Drugs in Patients on Extracorporeal Membrane Oxygenation: A Review of the Current Literature.
Sherwin J; Heath T; Watt K
Clin Ther; 2016 Sep; 38(9):1976-94. PubMed ID: 27553752
[TBL] [Abstract][Full Text] [Related]
7. The impact of extracorporeal membrane oxygenation on antifungal pharmacokinetics: A systematic review.
Jendoubi A; Pressiat C; De Roux Q; Hulin A; Ghaleh B; Tissier R; Kohlhauer M; Mongardon N
Int J Antimicrob Agents; 2024 Feb; 63(2):107078. PubMed ID: 38161046
[TBL] [Abstract][Full Text] [Related]
8. A Narrative Review of the Impact of Extracorporeal Membrane Oxygenation on the Pharmacokinetics and Pharmacodynamics of Critical Care Therapies.
Patel JS; Kooda K; Igneri LA
Ann Pharmacother; 2023 Jun; 57(6):706-726. PubMed ID: 36250355
[TBL] [Abstract][Full Text] [Related]
9. Antifungals in Patients With Extracorporeal Membrane Oxygenation: Clinical Implications.
Kriegl L; Hatzl S; Schilcher G; Zollner-Schwetz I; Boyer J; Geiger C; Hoenigl M; Krause R
Open Forum Infect Dis; 2024 Jun; 11(6):ofae270. PubMed ID: 38887481
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic changes of antibiotic, antiviral, antituberculosis and antifungal agents during extracorporeal membrane oxygenation in critically ill adult patients.
Hahn J; Choi JH; Chang MJ
J Clin Pharm Ther; 2017 Dec; 42(6):661-671. PubMed ID: 28948652
[TBL] [Abstract][Full Text] [Related]
11. Radical treatment for blastomycosis following unsuccessful liposomal amphotericin.
Chew C; Thapa N; Ogbuagu H; Varghese M; Patel D; Abbas R; Oh J; Teshome M; Mohammed K; Saleem S; Aggarwal D; Barns B; McDonald A; Ormenisan-Gherasim C
Lancet Infect Dis; 2022 Dec; 22(12):e377-e381. PubMed ID: 35809592
[TBL] [Abstract][Full Text] [Related]
12. Antifungal Dosing in Critically Ill Patients on Extracorporeal Membrane Oxygenation.
Lyster H; Shekar K; Watt K; Reed A; Roberts JA; Abdul-Aziz MH
Clin Pharmacokinet; 2023 Jul; 62(7):931-942. PubMed ID: 37300631
[TBL] [Abstract][Full Text] [Related]
13. Extracorporeal membrane oxygenation for blastomycosis-related acute respiratory distress syndrome: a case series.
Bednarczyk JM; Kethireddy S; White CW; Freed DH; Singal RK; Bell D; Ahmed SZ; Kumar A; Light B
Can J Anaesth; 2015 Jul; 62(7):807-15. PubMed ID: 25851019
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Altered Drug Pharmacokinetics in Critically Ill Adults Receiving Extracorporeal Membrane Oxygenation.
Ha MA; Sieg AC
Pharmacotherapy; 2017 Feb; 37(2):221-235. PubMed ID: 27931091
[TBL] [Abstract][Full Text] [Related]
15. Machines that help machines to help patients: optimising antimicrobial dosing in patients receiving extracorporeal membrane oxygenation and renal replacement therapy using dosing software.
Roberts JA; Bellomo R; Cotta MO; Koch BCP; Lyster H; Ostermann M; Roger C; Shekar K; Watt K; Abdul-Aziz MH
Intensive Care Med; 2022 Oct; 48(10):1338-1351. PubMed ID: 35997793
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of caspofungin and voriconazole in critically ill patients during extracorporeal membrane oxygenation.
Spriet I; Annaert P; Meersseman P; Hermans G; Meersseman W; Verbesselt R; Willems L
J Antimicrob Chemother; 2009 Apr; 63(4):767-70. PubMed ID: 19218271
[TBL] [Abstract][Full Text] [Related]
17. Isavuconazole plasma concentrations in critically ill patients during extracorporeal membrane oxygenation.
Kriegl L; Hatzl S; Zurl C; Reisinger AC; Schilcher G; Eller P; Gringschl Y; Muhr T; Meinitzer A; Prattes J; Hoenigl M; Krause R
J Antimicrob Chemother; 2022 Aug; 77(9):2500-2505. PubMed ID: 35726095
[TBL] [Abstract][Full Text] [Related]
18. Successful treatment of pulmonary blastomycosis with continuously infused amphotericin B deoxycholate after failure with liposomal amphotericin B.
Ariano RE; Mitchelmore BR; Lagacé-Wiens PR; Zelenitsky SA
Ann Pharmacother; 2013 Jun; 47(6):e26. PubMed ID: 23673538
[TBL] [Abstract][Full Text] [Related]
19. Recurrent central nervous system blastomycosis in an immunocompetent child treated successfully with sequential liposomal amphotericin B and voriconazole.
Panicker J; Walsh T; Kamani N
Pediatr Infect Dis J; 2006 Apr; 25(4):377-9. PubMed ID: 16567998
[TBL] [Abstract][Full Text] [Related]
20. Voriconazole pharmacokinetics in a critically ill patient during extracorporeal membrane oxygenation.
Lin XB; Hu XG; Xia YZ; Liu XM; Liang T; Chen X; Cai CJ
J Chemother; 2022 Jul; 34(4):272-276. PubMed ID: 34904531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
